- Home
- NFGC vs QURE Comparison
NFGC vs QURE Comparison
Compare NFGC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFGC
- QURE
- Stock Information
- Founded
- NFGC 2016
- QURE 1998
- Country
- NFGC Canada
- QURE Netherlands
- Employees
- NFGC N/A
- QURE N/A
- Industry
- NFGC Precious Metals
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- NFGC Basic Materials
- QURE Health Care
- Exchange
- NFGC Nasdaq
- QURE Nasdaq
- Market Cap
- NFGC 511.6M
- QURE 432.6M
- IPO Year
- NFGC N/A
- QURE 2007
- Fundamental
- Price
- NFGC $2.49
- QURE $5.65
- Analyst Decision
- NFGC Strong Buy
- QURE Buy
- Analyst Count
- NFGC 1
- QURE 5
- Target Price
- NFGC $9.00
- QURE $19.40
- AVG Volume (30 Days)
- NFGC 593.1K
- QURE 555.8K
- Earning Date
- NFGC 11-11-2024
- QURE 11-05-2024
- Dividend Yield
- NFGC N/A
- QURE N/A
- EPS Growth
- NFGC N/A
- QURE N/A
- EPS
- NFGC N/A
- QURE N/A
- Revenue
- NFGC N/A
- QURE $27,707,000.00
- Revenue This Year
- NFGC N/A
- QURE $187.60
- Revenue Next Year
- NFGC N/A
- QURE $51.90
- P/E Ratio
- NFGC N/A
- QURE N/A
- Revenue Growth
- NFGC N/A
- QURE N/A
- 52 Week Low
- NFGC $2.27
- QURE $3.73
- 52 Week High
- NFGC $4.60
- QURE $11.35
- Technical
- Relative Strength Index (RSI)
- NFGC 43.15
- QURE 53.92
- Support Level
- NFGC $2.48
- QURE $4.45
- Resistance Level
- NFGC $2.69
- QURE $5.27
- Average True Range (ATR)
- NFGC 0.17
- QURE 0.38
- MACD
- NFGC -0.01
- QURE 0.04
- Stochastic Oscillator
- NFGC 16.67
- QURE 74.07
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.